These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6303528)

  • 61. Localization of ouabain-binding sites in frog gastric mucosa.
    Helander HF; Durbin RP
    Am J Physiol; 1982 Oct; 243(4):G297-303. PubMed ID: 6982004
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump.
    Schneider R; Wray V; Nimtz M; Lehmann WD; Kirch U; Antolovic R; Schoner W
    J Biol Chem; 1998 Jan; 273(2):784-92. PubMed ID: 9422732
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A labile sodium pump inhibitor from the peritoneal dialysate of hypertensive renal failure patients: estimates of potency.
    Graves SW; Tao QF; Markides KE; Williams GH; Hollenberg NK
    Clin Exp Hypertens; 1998; 20(5-6):611-6. PubMed ID: 9682917
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evidence of a blunted response to ouabain in canine transplanted heart with acute rejection.
    Dumont L; Lord C; Trelles L; Chartrand C
    Transplant Proc; 1988 Dec; 20(6):1228-30. PubMed ID: 3059608
    [No Abstract]   [Full Text] [Related]  

  • 65. Identification, purification and partial characterization of low molecular weight protein inhibitor of Na⁺/K⁺-ATPase from pulmonary artery smooth muscle cells.
    Rahaman SM; Dey K; Das P; Roy S; Chakraborti T; Chakraborti S
    Mol Cell Biochem; 2014 Aug; 393(1-2):309-17. PubMed ID: 24850186
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Quantitative structure-activity relationship studies on Na+,K(+)-ATPase inhibitors.
    Gupta SP
    Chem Rev; 2012 Jun; 112(6):3171-92. PubMed ID: 22360614
    [No Abstract]   [Full Text] [Related]  

  • 67. Characterization and partial purification of the sodium-potassium-ATPase inhibitor released from cultured rat hypothalamic cells.
    Morgan K; Lewis MD; Spurlock G; Collins PA; Foord SM; Southgate K; Scanlon MF; Mir MA
    J Biol Chem; 1985 Nov; 260(25):13595-600. PubMed ID: 2997173
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A rapid assay for the measurement of Na+,K(+)-ATPase inhibitors.
    Chan EL; Swaminathan R
    Clin Biochem; 1992 Feb; 25(1):15-9. PubMed ID: 1312916
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The anticancer drug perillyl alcohol is a Na/K-ATPase inhibitor.
    Garcia DG; Amorim LM; de Castro Faria MV; Freire AS; Santelli RE; Da Fonseca CO; Quirico-Santos T; Burth P
    Mol Cell Biochem; 2010 Dec; 345(1-2):29-34. PubMed ID: 20689980
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Purification and characterization of a Na+, K+ ATPase inhibitor found in an endotoxin of Leptospira interrogans.
    Burth P; Younes-Ibrahim M; Gonçalez FH; Costa ER; Faria MV
    Infect Immun; 1997 Apr; 65(4):1557-60. PubMed ID: 9119504
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Erythrocyte 3H-ouabain binding and digitalis treatment in ethanol addicted patients.
    Battaini F; Govoni S; Mauri A; Civelli L; Trabucchi M
    Life Sci; 1987 Jun; 40(26):2505-9. PubMed ID: 2885700
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cardiac glycoside interactions at 'silent' and at active receptors. Putative biochemical backgrounds and possible clinical relevance.
    Offerhaus L
    Neth J Med; 1985; 28(10):393-400. PubMed ID: 3001546
    [No Abstract]   [Full Text] [Related]  

  • 73. Structure-activity relationship of wedelolactone analogues: structural requirements for inhibition of Na+, K+ -ATPase and binding to the central benzodiazepine receptor.
    Pôças ES; Lopes DV; da Silva AJ; Pimenta PH; Leitão FB; Netto CD; Buarque CD; Brito FV; Costa PR; Noël F
    Bioorg Med Chem; 2006 Dec; 14(23):7962-6. PubMed ID: 16945543
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aplysiallene, a new bromoallene as an Na, K-ATPase inhibitor from the sea hare, Aplysia kurodai.
    Okamoto Y; Nitanda N; Ojika M; Sakagami Y
    Biosci Biotechnol Biochem; 2001 Feb; 65(2):474-6. PubMed ID: 11302194
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Complete purification of two identical Na(+)-pump inhibitors isolated from bovine hypothalamus and hypophysis.
    Illescas M; Ricote M; Mendez E; G-Robles R; Sancho J
    FEBS Lett; 1990 Feb; 261(2):436-40. PubMed ID: 2155831
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Separation from uremic body fluids and normal urine of Na+, K+-ATPase inhibitor.
    Gallice P; Monti JP; Braguer D; Durand C; Manchon H; Murisasco A; Crevat A
    Adv Exp Med Biol; 1987; 223():215-8. PubMed ID: 2833847
    [No Abstract]   [Full Text] [Related]  

  • 77. Differential inactivation of Na,K-ATPase by erythrosin isothiocyanate.
    Taylor M; Owen D; Tariq A; Cavieres JD
    Ann N Y Acad Sci; 2003 Apr; 986():270-2. PubMed ID: 12763818
    [No Abstract]   [Full Text] [Related]  

  • 78. Effect of high salt intake on plasma and tissue concentration of endogenous ouabain-like substance in the rat.
    Butt AN; Semra YK; Ho CS; Swaminathan R
    Life Sci; 1997; 61(24):2367-73. PubMed ID: 9399628
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proscillaridin A immunoreactivity: its purification, transport in blood by a specific binding protein and its correlation with blood pressure.
    Schneider R; Antolovic R; Kost H; Sich B; Kirch U; Tepel M; Zidek W; Schoner W
    Clin Exp Hypertens; 1998; 20(5-6):593-9. PubMed ID: 9682915
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Various aspects of sodium metabolism in hypertension].
    Debiński W; Wocial B
    Pol Tyg Lek; 1982 Nov; 37(44):1339-42. PubMed ID: 6298758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.